Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

China · Delayed Price · Currency is CNY

30.73

+1.56 (5.35%)

Aug 4, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing	184.33M	202.97M	310.46M	308.45M	447.34M
Pharmaceutical Wholesale and Retail	36.35M	144.04M	204.09M	220.96M	183.84M
Unallocated Other Operating Revenue/Costs	-	4.19M	5.07M	3.03M	1.77M
Other Operating Revenue/Costs	4.60M	-	-	-	-
Total	225.27M	351.20M	519.62M	532.44M	632.95M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	225.27M	351.20M	519.62M	532.44M	632.95M
Total	225.27M	351.20M	519.62M	532.44M	632.95M